-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-520565-51-00
5
small cell lung cancer
-
2025-522511-42-00
4
Crohn's disease
-
2025-522279-27-00
5
2026-04-02
Newly Diagnosed AML with an NPM1 mutation
-
2024-520209-38-00
5
2025-09-19
Obesity or Overweight
-
2023-509606-30-00
5
2024-07-24
Ulcerative colitis
-
2023-504214-30-00
5
2024-06-27
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
-
2022-500544-38-00
5
2023-06-05
Advanced Breast Cancer
-
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2025-521670-34-00
5
2026-03-04
Acute coronary syndrome (ST-elevation myocardial infarction [STEMI] or
-
2025-522873-12-00
5
2026-02-24
ER+, HER2- Advanced Breast Cancer
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2025-521382-27-00
10
2025-12-04
Moderately to Severely Active Crohn's Disease
-
2025-521381-10-00
5
2025-12-03
Moderately to Severely Active Ulcerative Colitis
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2024-520210-21-00
5
2025-09-19
Crohn’s Disease
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-519525-38-00
5
2025-08-22
Heart failure
-
2024-513053-69-00
5
2025-04-16
Moderately to Severely Active Crohn's Disease (CD)
-
2024-512633-32-00
4
2025-04-07
Crohn's disease
-
2024-515566-13-00
5
2025-03-19
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2024-514281-39-00
5
2025-02-14
Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD
-
2024-515008-38-00
5
2025-02-14
Metastatic Non-squamous Non-small Cell Lung Cancer Whose Tumors Expres